Search results
Ted Danson Has Lived With Psoriasis for 50 Years—Here Are the Dermatologist-Approved Ways He Combats...
Eating Well via Yahoo News· 3 hours agoActor Ted Danson and dermatologist Jennifer Soung shared the importance of seeking care for...
‘I Tried Out For A Reality Dating Show But Got Ghosted After My Photos Showed My Psoriasis’
Women's Health via Yahoo News· 5 days agoMichelle Lee had an itchy skin rash from plaque psoriasis for months, but doctors mistook it for an...
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer
Morningstar· 10 hours agoOruka Therapeutics, Inc. (“Oruka”), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including ...
Ted Danson on Managing His Psoriasis With Humor
WebMD· 1 day agoActor Ted Danson, known for his roles on sitcoms like Cheers and The Good Place, was diagnosed with plaque psoriasis when he was 25 years old. Danson, now ...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 2 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
What Can Cause a Rash Around the Eyes?
Verywell Health via Yahoo News· 2 days agoMany conditions can cause a rash around the eyes, from infections to dermatological conditions like dermatitis or psoriasis. Here’s what you need to...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 5 hours agoLOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of Ventyx Biosciences, Inc. (“Ventyx” or
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 2 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...
Morningstar· 4 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ventyx Biosciences, Inc ...
UCB SA (OTCMKTS:UCBJY) Declares Dividend of $0.46
ETF DAILY NEWS· 4 days agoUCB SA (OTCMKTS:UCBJY – Get Free Report) declared a dividend on Friday, April 19th, investing.com reports. Stockholders of record on Monday, April 29th will be given a dividend of 0.4574 per ...
